Research

Macro partitioning

Low-Carbohydrate High-Fat (LCHF) and Ketogenic diets do not significantly alter ALT levels in individuals with MASLD compared to control diets.

Current evidence from this meta-analysis does not support LCHF or Ketogenic diets as significantly effective for lowering liver enzymes (ALT) in people with MASLD compared to control diets. The wide variation in how 'low-carb' was defined across studies makes it difficult to draw firm conclusions, but it did not show the significant benefits seen with fasting or MedDiet.

ModerateRefutesMEDIUM confidence
LCHF/ketogenic diets (n = 6) and Omega-3 fatty acids supplementation (n = 4) did not significantly alter ALT.
Ute Stern et al. · European Journal of Nutrition · 2026

Why this rating

Meta-analysis of 6 RCTs, but results were non-significant with substantial heterogeneity.

Source

The impact of dietary interventions on liver health biomarkers in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic literature review and meta-analysis of randomized controlled trials

Ute Stern et al. · European Journal of Nutrition · 2026

DOI 10.1007/s00394-025-03870-z

Meta-analysis · 24 studiesCited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →